Publication Ethics

The Global Medical Reviews (GMR) is committed to the highest standards of publication ethics and integrity in research dissemination. All stakeholders in the publication process — authors, editors, reviewers, and the publisher — must follow internationally recognized principles to ensure transparency, accountability, and trust in scholarly publishing.

This policy is aligned with the recommendations of:

1. Authorship and Contributions

  • 1.1 Authorship must be based on substantial intellectual contribution to conception, design, data acquisition, analysis, or interpretation, as well as drafting or critically revising the manuscript.
  • 1.2 All authors must approve the final version and accept responsibility for the accuracy and integrity of the work.
  • 1.3 Contributions not meeting authorship criteria (e.g., technical support, data collection, funding acquisition) should be acknowledged.
  • 1.4 Authorship disputes will be resolved following COPE and ICMJE recommendations.

2. Conflicts of Interest

  • 2.1 Authors, reviewers, and editors must disclose any actual or potential conflicts of interest (financial, professional, personal) that may influence objectivity.
  • 2.2 Authors must complete a conflict of interest statement at submission; disclosures will be published with the article.
  • 2.3 Editors and reviewers must withdraw from handling a manuscript if conflicts are identified.

3. Funding and Sponsorship

  • 3.1 All sources of financial support must be declared in the manuscript.
  • 3.2 The role of funders in study design, data collection, analysis, interpretation, or manuscript preparation must be specified.

4. Human and Animal Ethics

  • 4.1 General compliance: GMR aligns with the principles of the Declaration of Helsinki for research involving humans and with internationally accepted standards for animal welfare.
  • 4.2 Scope of the journal: As GMR publishes only review-based articles (systematic reviews, meta-analyses, scoping, and narrative reviews), authors are not required to provide individual patient consent forms or institutional ethics approval.
  • 4.3 Responsibility of authors: Authors must ensure that all studies included in their reviews were conducted in accordance with recognized ethical standards, including appropriate human and animal research approvals as reported in the original publications.
  • 4.4 Reproduced material: If a review article contains reproduced material (e.g., images, tables, or figures) from previously published sources, the authors are responsible for securing permission from the original copyright holder and clearly acknowledging the source.

5. Confidentiality

  • 5.1 Manuscripts are treated as confidential documents during peer review.
  • 5.2 Reviewers must not share, distribute, or discuss manuscripts with third parties.
  • 5.3 Authors must remove identifying information to maintain double-blind review.

6. Plagiarism and Research Misconduct

  • 6.1 All submissions undergo plagiarism screening with antiplagiat.ru.
  • 6.2 Manuscripts with similarity above 20% may be returned or rejected at the editors’ discretion.
  • 6.3 Plagiarism, self-plagiarism, fabrication, falsification, duplicate submission, and copyright infringement constitute serious misconduct and may lead to rejection, retraction, or notification to institutions.

7. Data Sharing and Reproducibility

  • 7.1 Transparency of sources: Since GMR publishes only review articles, authors are not required to share raw primary data. However, they must provide clear descriptions of the databases searched, search strategies, inclusion/exclusion criteria, and methods of analysis to ensure reproducibility of the review process.
  • 7.2 Protocol registration: For systematic reviews and meta-analyses, authors are encouraged to register their review protocols in internationally recognized registries, such as PROSPERO. The registration number, if available, should be included in the manuscript.
  • 7.3 Data availability statements: Authors should include a brief statement indicating whether supplementary materials related to their review (e.g., detailed search strategies, data extraction tables, or additional analyses) are available to readers.
  • 7.4 Use of reporting guidelines: All submissions must follow internationally recognized reporting standards for reviews, such as the PRISMA guidelines. Authors should upload a completed PRISMA checklist alongside their manuscript.

8. Complaints and Appeals

  • 8.1 Authors may appeal editorial decisions by providing a detailed justification to the editorial office.
  • 8.2 Appeals and complaints will be reviewed according to COPE flowcharts and handled fairly and transparently.

9. Post-publication Corrections and Retractions

  • 9.1 Minor errors not affecting scientific validity will be corrected via errata or corrigenda.
  • 9.2 Serious errors or misconduct (e.g., plagiarism, falsified data) will result in article retraction, following COPE Retraction Guidelines.
  • 9.3 All corrections and retractions will be clearly linked to the original publication.

10. Use of Artificial Intelligence Tools

  • 10.1 AI authorship: Generative AI tools (e.g., ChatGPT) do not meet authorship criteria; human accountability is required.
  • 10.2 AI in manuscript preparation: Authors must declare AI-assisted language editing or figure generation in the Methods or Acknowledgments.
  • 10.3 AI in peer review: Reviewers must not upload manuscripts into AI systems. Any AI support used in evaluation must be disclosed.
  • 10.4 The journal follows WAME recommendations on chatbots and AI in scholarly publishing.

11. Intellectual Property and Copyright

  • 11.1 Authors retain copyright of their work under a Creative Commons Attribution (CC BY 4.0) License.
  • 11.2 Authors are responsible for securing permissions for copyrighted material.
  • 11.3 Reuse, adaptation, or distribution of published content is permitted provided appropriate citation is given.